Where and When to Apply Upstream Process Intensification Technologies

Where and When to Apply Upstream Process Intensification Technologies

Biopharmaceutical process intensification may be applied to multiple points in the workflow to increase productivity by orders of magnitude for diverse modalities, including recombinant proteins, vaccines, cell therapies, plasmid DNA and cultured meat. This webinar describes application of XCell ATF® Technology to the seed train and the production (N) bioreactor in different modes to create time, cost and facility efficiencies. 15+ years of published application data, implementation in the largest number of commercial processes and proven scaling from 1 L to 5000 L differentiate XCell ATF® Technology from all other upstream intensification methods. Considerations for when and why to apply XCell ATF® Technology in order to meet specific productivity goals will be discussed.